Sanofi paid $11.85 million for violating FCA by unlawfully subsidizing co-pays for its drug Lemtrada
Register to read the full analysis —or— Upgrade to access more features
#bias
#fcpa
#fraud
#permits
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.